BOGOTA, Colombia – With an investment of $5.5 million in Costa Rica, Swiss major Roche AG is expanding its operations in Central America and the Caribbean after almost doubling its business in a few years.

BOGOTA, Colombia – Most Latin American countries are developing new regulations and guidelines in an effort to facilitate the use of novel drugs and biosimilars in their health care systems. Bolivia, with a political regime in transition, stands as an exception in the region.

BOGOTA, Colombia – Biosimilar makers and distributors are looking at the small but growing markets in Latin America to not only reach new consumers, but also pave the way for entry into more developed markets.

BOGOTA, Colombia – Economic integration processes among Latin American countries are playing a key role in outlining regulatory standards for the life sciences industry.